Development of an In-House Genetic Screening Toolbox to Select and Grow Pathogen-Resistant Strains of Cannabis sativa.

开发内部基因筛选工具箱来选择和种植大麻的病原体抗性菌株。

• 批准号: 567026-2021
• 负责人: Méthot, Nathalie
• 金额: $ 1.81万
• 依托单位: La Cité collégiale
• 依托单位国家: 加拿大
• 项目类别: Applied Research and Development Grants - Level 1
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=723903
• 关键词: Development; House; Genetic; Screening; Toolbox

LyonLeaf Cannabis Inc. is a federally licensed producer of premium cannabis and aims to close the gap inpatients' needs for standardized medical cannabis. It is committed to contributing to the body of research oncultivation of cannabis in industrial settings, as well as research on effects of cannabis product derivatives on health and well-being of medical patients. Understanding of resistance of cannabis strains to commonpathogens will help in identifying those strains that are not prone to diseases, and therefore may be more easily commercialized. The Technology Access Centre in Bio-Innovation at College La Cité would provide LyonLeafwith the knowledge, expertise and capabilities to assess which pathogens are present in their crop and develop techniques to select pathogen resistant genotypes that will be able to thrive where the present susceptiblegenotypes do not. This collaborative research project between LyonLeaf and La Cité would involve geneticmarker identification of common pathogens, genetic analyses using molecular biology equipment, andvalidation of methodology by application and observation of pathogen to cannabis plantlets. At the end of this project, LyonLeaf should be able to autonomously develop new varieties resistant to the pathogens encounteredin their facility, toward a more sustainable production which will help strengthen their position in the national market.

LyonLeaf Cannabis Inc .是一家获得联邦许可的优质大麻生产商，旨在缩小住院患者对标准化医用大麻的需求差距，致力于促进工业环境中大麻种植的研究以及大麻影响的研究。了解大麻菌株对常见病原体的抵抗力将有助于识别那些不易患病的菌株，因此可能更容易商业化。拉西特学院的生物创新将为 LyonLeaf 提供知识、专业知识和能力，以评估其作物中存在哪些病原体，并开发技术来选择病原体抗性基因型，这些基因型将能够在目前易感基因型无法生长的地方茁壮成长。 LyonLeaf 和 La Cité 之间的项目将涉及常见病原体的遗传标记鉴定、使用分子生物学设备进行遗传分析以及通过对大麻应用和观察病原体来验证方法。 LyonLeaf 应该能够自主开发能够抵抗其设施中遇到的病原体的新品种，以实现更可持续的生产，这将有助于巩固其在全国市场的地位。